|
|
|
Volumn 43, Issue 2, 1999, Pages 125-131
|
|
Clinical imaging of multidrug resistance in cancer
a
|
|
Author keywords
Drug resistance, multiple; Drug resistance, neoplasm; P Glycoprotein; Technetium T 99mSestamibi; Tumor retention
|
|
Indexed keywords
ADENOSINE TRIPHOSPHATE;
ANTINEOPLASTIC AGENT;
CATION;
CYCLOSPORIN A;
DNA TOPOISOMERASE (ATP HYDROLYSING);
FLUORODEOXYGLUCOSE F 18;
FURIFOSMIN TC 99M;
GLUTATHIONE TRANSFERASE;
GLYCOPROTEIN P;
MEMBRANE PROTEIN;
METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;
MULTIDRUG RESISTANCE PROTEIN;
TECHNETIUM 99M;
TETROFOSMIN TC 99M;
VALSPODAR;
VERAPAMIL;
AREA UNDER THE CURVE;
AUTORADIOGRAPHY;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG CLEARANCE;
DRUG TRANSPORT;
DRUG UPTAKE;
HUMAN;
IMAGING;
IMMUNOBLOTTING;
MALIGNANT NEOPLASTIC DISEASE;
MONITORING;
MULTIDRUG RESISTANCE;
NONHUMAN;
PHENOTYPE;
POSITRON EMISSION TOMOGRAPHY;
PROTEIN EXPRESSION;
DRUG RESISTANCE, MULTIPLE;
DRUG RESISTANCE, NEOPLASM;
FEASIBILITY STUDIES;
FORECASTING;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
LUNG NEOPLASMS;
NEOPLASMS;
P-GLYCOPROTEINS;
PHENOTYPE;
RADIOPHARMACEUTICALS;
SUBSTRATE SPECIFICITY;
TECHNETIUM TC 99M SESTAMIBI;
TREATMENT FAILURE;
|
|
EID: 0033014490
PISSN: 11243937
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (28)
|
|
References (47)
|
